Cargando…

Zinc‐finger E‐box‐binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib

BACKGROUND: Zinc‐finger E‐box‐binding homeobox 1 (ZEB1) is an important regulator of epithelial‐mesenchymal transition (EMT) and is involved in the maintenance of cancer stem cells (CSCs) via miR‐200c and BMI1 pathway. Recent studies revealed that ZEB1 contributes to the EMT‐mediated acquired resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nurwidya, Fariz, Takahashi, Fumiyuki, Winardi, Wira, Tajima, Ken, Mitsuishi, Yoichiro, Murakami, Akiko, Kobayashi, Isao, Nara, Takeshi, Hashimoto, Muneaki, Kato, Motoyasu, Hidayat, Moulid, Suina, Kentaro, Hayakawa, Daisuke, Asao, Tetsuhiko, Ko, Ryo, Shukuya, Takehito, Yae, Toshifumi, Shimada, Naoko, Yoshioka, Yasuko, Sasaki, Shinichi, Takahashi, Kazuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107025/ https://www.ncbi.nlm.nih.gov/pubmed/33764690 http://dx.doi.org/10.1111/1759-7714.13937

Ejemplares similares

Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with EGFR T790M mutation
por: Hayakawa, Daisuke, et al.
Publicado: (2019)

Strategies for an effective tobacco harm reduction policy in Indonesia
por: Nurwidya, Fariz, et al.
Publicado: (2014)

CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma
por: Kanamori, Koichiro, et al.
Publicado: (2023)

Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutation
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines
por: Xu, Shiting, et al.
Publicado: (2023)

Hypoxia Increases Gefitinib-Resistant Lung Cancer Stem Cells through the Activation of Insulin-Like Growth Factor 1 Receptor
por: Murakami, Akiko, et al.
Publicado: (2014)

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
por: Kato, Motoyasu, et al.
Publicado: (2014)

Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway
por: Kato, Motoyasu, et al.
Publicado: (2020)

Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer—is there a “tail plateau” in the survival curve of these patients?
por: Shimamura, Shoko Sonobe, et al.
Publicado: (2022)

Impact of the generation of EGFR‐TKIs administered as prior therapy on the efficacy of osimertinib in patients with non‐small cell lung cancer harboring EGFR T790M mutation
por: Miyashita, Yosuke, et al.
Publicado: (2020)

Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study
por: Kurokawa, Kana, et al.
Publicado: (2022)

Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small‐cell lung cancer
por: Kurokawa, Kana, et al.
Publicado: (2022)

Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012)

Molecular Mechanisms Contributing to Resistance to Tyrosine Kinase-Targeted Therapy for Non-Small Cell Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012)

From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers
por: Nurwidya, Fariz, et al.
Publicado: (2012)

Hochuekkito (TJ-41), a Kampo Formula, Ameliorates Cachexia Induced by Colon 26 Adenocarcinoma in Mice
por: Yae, Suzu, et al.
Publicado: (2012)

TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells
por: Itoigawa, Yukinari, et al.
Publicado: (2015)

Regional heterogeneity in response of airway epithelial cells to cigarette smoke
por: Baskoro, Hario, et al.
Publicado: (2018)

SCLC-J1, a novel small cell lung cancer cell line
por: Ohara, Kazuo, et al.
Publicado: (2021)

Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt–Hogg–Dubé syndrome
por: Hoshika, Yoshito, et al.
Publicado: (2016)

Hermansky-Pudlak syndrome-associated pneumothorax with rapid progression of respiratory failure: a case report
por: Kato, Yukari, et al.
Publicado: (2020)

Cerebral infarction in advanced non-small cell lung cancer: a case control study
por: Kato, Motoyasu, et al.
Publicado: (2016)

Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis
por: Xu, Shiting, et al.
Publicado: (2022)

Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B‐containing N‐methyl‐d‐aspartate–sensitive glutamate receptor signaling
por: Suina, Kentaro, et al.
Publicado: (2018)

Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study
por: Nakamura, Kota, et al.
Publicado: (2017)

The Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary Disease
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Dramatic, significant metabolic response to a one‐time pembrolizumab treatment following a relapse of pre‐existing organizing pneumonia in a patient with advanced non‐small cell lung cancer: A case report
por: Kato, Motoyasu, et al.
Publicado: (2021)

Highly sensitive fusion detection using plasma cell‐free RNA in non‐small‐cell lung cancers
por: Hasegawa, Nobuhiko, et al.
Publicado: (2021)

The Functional Role of Zinc Finger E Box-Binding Homeobox 2 (Zeb2) in Promoting Cardiac Fibroblast Activation
por: Jahan, Fahmida, et al.
Publicado: (2018)

Bevacizumab‐induced chronic interstitial pneumonia during maintenance therapy in non‐small cell lung cancer
por: Sekimoto, Yasuhito, et al.
Publicado: (2016)

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study
por: Ono, Akira, et al.
Publicado: (2013)

The correlation of age and body mass index with the level of both protease MMP3 and anti-protease TIMP-1 among Indonesian patients with chronic obstructive pulmonary disease: a preliminary findings
por: Mulyadi, et al.
Publicado: (2018)

Molecular Diagnosis of Tuberculosis
por: Nurwidya, Fariz, et al.
Publicado: (2018)

Nigella sativa as an anti-inflammatory agent in asthma
por: Ikhsan, Mukhtar, et al.
Publicado: (2018)

Spirometry findings among drug users in the Indonesian National Narcotics and illicit drug Bureau Rehabilitation Center
por: Samoedro, Erlang, et al.
Publicado: (2017)

Rate of Forced Expiratory Volume in One Second and Forced Expiratory Volume in One Second/Forced Vital Capacity Decline among Indonesian Patients with Chronic Obstructive Pulmonary Disease after a Year of Treatment
por: Ariawan, Wily Pandu, et al.
Publicado: (2019)

Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Akamatsu, Hiroaki, et al.
Publicado: (2014)

Birt–Hogg–Dubé syndrome in an Indonesian patient with folliculin gene mutation
por: Wiyono, Wiwien Heru, et al.
Publicado: (2016)

The role of insulin receptor substrate 1 gene polymorphism Gly972Arg as a risk factor for ischemic stroke among Indonesian subjects
por: Syahrul, et al.
Publicado: (2018)

LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer
por: Jotatsu, Takanobu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_efnkp5r7o4arroen9tlvr86fp0